Boston Children’s remains at the forefront of research and innovation during the COVID-19 pandemic. Learn about our recent advances.
Spatial modeling of vaccine ‘deserts’ as barriers to controlling COVID-19
Analysis of a website called VaccineFinder shows that in 2021, more than 10 percent of U.S. residents had poor access to COVID-19 vaccines. Vaccines were less available to people in rural areas, people of color, and people with chronic illnesses.
Powerful new antibody neutralizes all known coronavirus variants
As COVID-19 wears on, new variants have found ways to evade our antibody responses, leading to breakthrough cases. Now, Boston Children’s researchers have made antibodies that neutralize all strains of the virus, including all Omicron variants known at the time.
How protected am I from COVID-19? A new test could tell you at home
Say you’re going to a wedding or are about to travel. You’ve been vaccinated against COVID-19, but you have an underlying medical condition. How protected is your family? Do you need another booster? A new home test could give answers within 15 minutes.
Lingering health problems in children and youth after COVID-19 and MIS-C
More than 1 in 4 children and adolescents hospitalized with COVID-19 or MIS-C early in the pandemic were still not well up to four months later, and 15 to 20 percent had not resumed their previous activity, this national study finds.
Previous COVID-19 or MIS-C does not protect kids from Omicron
Unvaccinated children and teens remain susceptible to the coronavirus, especially the Omicron variant, a national study finds.
COVID-19’s devastating toll: An increase in adolescent suicides and mental health crises
Two studies from Boston Children’s Hospital show that the trend of increased self-harm, suicidal ideation, and suicide attempts by teens became even more acute with the onset of COVID-19.
How COVID-19 triggers massive inflammation
The SARS-CoV-2 virus infects and kills critical immune cells in the blood and lungs, which set off powerful alarm bells as they die, according to a study.
A new symptom of COVID-19 in young children: Croup
During the Omicron surge, pediatricians and emergency departments began noticing a trend.
Pregnant mothers who get COVID-19 vaccines are also protecting their babies
Research co-led by Dr. Adrienne Randolph and the CDC estimates that vaccinating expectant moms reduced the chances their babies would be hospitalized with severe COVID-19 by 60 percent. Dr. Randolph explains in a Q&A.
Joining the fight against COVID: Women scientists at Boston Children’s are leading the way
When COVID-19 hit, these physician-scientists at Boston Children’s pivoted to studying the new coronavirus and its effects. Here, they share their paths and offer their advice on going into science.
A respiratory model of COVID-19, made from patients’ own cells
An engineered airway lining, made from patients’ own cells, is helping scientists understand how COVID-19 affects the respiratory tract, and can be used to test potential drugs.
COVID-19 vaccination in 12- to 18-year-olds: What does the science say?
Drs. Jane Newburger and Adrienne Randolph led three major studies that confirm vaccination’s protective benefits against both COVID-19 and MIS-C, which far outweigh rare side effects.
Contact phone
From our labs and clinics: The top 10 COVID-19 science stories of 2021
In 2021, researchers in all corners of Boston Children’s documented the clinical and immunological effects of COVID-19 and investigated new vaccines, diagnostics, and therapeutics.
Emerging protein-based COVID-19 vaccines could be game-changing
Two separate programs at Boston Children’s have developed protein-based COVID-19 vaccines that could be cheaper and easier to store than mRNA vaccines.
What makes the Delta variant of COVID-19 so contagious?
A structural analysis shows that Delta’s spike protein is especially good at fusion, allowing the virus to enter people’s cells very rapidly.
Unpacking the body’s interferon response to COVID-19
Are interferons helpful or harmful in COVID-19? This detailed study finds that it depends which interferons, when they’re produced, and where.
Rapid saliva test detects COVID-19 variants, at home or point of care
A low-cost test system, designed by Dr. Rose Lee and collaborators at the Wyss Institute, can give a readout from users’ spit within about an hour. The researchers hope to see it made available commercially.
Why do some people get severe COVID-19? The nose may know
The body’s first encounter with SARS-CoV-2 happens in the nose and throat. Responses in this early battleground help determine who will develop severe COVID-19 and who won’t.
Children with severe MIS-C do better with IVIG and steroids as initial therapy
Children given the combined treatment up front had better cardiovascular outcomes, finds a large study in The New England Journal of Medicine.
A coming wave of diabetes? The link with COVID-19
Many patients hospitalized with COVID-19 early in the pandemic developed hyperglycemia, or abnormally high blood sugar levels.
What drives severe lung inflammation in COVID-19?
A new study finds that excess Notch4 protein on regulatory T-cells leads to severe lung inflammation in COVID-19.
COVID-19 takes its toll on kids’ mental health
Child hospitalizations for self-harm and suicide attempts stayed steady in 2020, even as hospitalizations for almost all other reasons fell by about half compared with 2017-2019.
New findings show risk of bleeding and clotting after COVID-19
Some patients with congenital heart disease and COVID-19 develop a tendency for blood clots or bleeding issues, even if they had minor COVID-19 symptoms.
Sturdier spikes may explain SARS-CoV-2 variants’ faster spread
Why do the new COVID-19 variant strains spread so quickly? Research by Dr. Bing Chen finds that a mutation carried by the U.K., South Africa, and Brazil strains strengthens the coronavirus spike, rendering the virus better able to infect us.
Neurological involvement common in kids and teens with acute COVID-19 and MIS-C
About 1 in 5 hospitalized patients had neurologic involvement, mainly fatigue, headache, confusion, trouble walking/crawling, and loss of taste/smell. Of these, 1 in 8 developed serious conditions such as stroke, encephalitis, and Guillain-Barre syndrome.
If another pandemic hits, our online ‘footprints’ may help the experts
Looking back at the early days of COVID-19, two Boston Children’s studies demonstrate the potential predictive value of tracking the public’s digital activity (and that of healthcare professionals) in guessing the enemy’s next moves.
Is it MIS-C or severe COVID-19? An update on multisystem inflammatory syndrome in children
Funded by the CDC, this national study led by Dr. Adrienne Randolph compared and contrasted MIS-C with severe, acute COVID-19 in more than 1,100 children. While the two conditions share some features, there are also important differences.
How do patients with cystic fibrosis respond to COVID-19? An ‘airway in a dish’ may give answers
Few COVID-19 cases have been noted in patients with cystic fibrosis. Are they protected, or just practicing good social distancing? This study is using an airway lining, engineered from patient-derived cells, to model the effects of SARS-CoV-2 in CF and test possible treatments.
How does the placenta protect unborn babies from COVID-19?
Being pregnant is a risk factor for severe COVID-19 in women who are exposed. Yet only 5% of their babies are born with the infection, and nearly all are doing very well. Dr. Elizabeth Taglauer is studying the placenta to see how it may be protecting babies.
Capturing SARS-CoV-2’s shape-shifting spike protein
The SARS-CoV-2 spike protein, the one our antibodies target, has two forms. New work provides a snapshot of both, with implications for COVID vaccines.
Type III interferon in COVID-19: Protective or harmful?
At least two clinical trials are testing type III interferon in COVID-19 to fight viral infection and limit inflammatory damage. But a new study led by Dr. Ivan Zanoni at Boston Children’s warns that if it’s given later in the illness, it could increase susceptibility to bacterial “superinfection."
Disulfiram inhibits inflammatory gatekeeper protein: Could it be helpful in COVID-19?
Inflammation is the alarm system by which cells first respond to potential danger. But in excess, inflammation can be deadly.
Making an IMPACC: Examining immune responses in people hospitalized with COVID-19
Boston Children’s Hospital will play key roles in the IMPACC study examining the body's immune response over time in patients hospitalized with COVID-19.
How the new coronavirus gets into respiratory tissue — and may exploit one of our defenses
What makes SARS-CoV-2 such a threat? A study suggests that it may exploit one of our main defenses against viruses to infect three specific cell types.
Boston Children’s Hospital to lead nationwide study on COVID-19 in children
A nationwide CDC-funded study of COVID-19 in children is asking why children are largely spared, and why a tiny handful become very ill with the virus.
